Combination therapy: Hypoxia modification with radiotherapy for bladder cancer

Nature Reviews Clinical Oncology

Volumn 8, Issue 3, 2011, Pages 129-130

  Gospodarowicz, Mary ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOGEN; CISPLATIN; NICOTINAMIDE;

ARTICLE; BLADDER CANCER; CANCER RADIOTHERAPY; CANCER SURVIVAL; CYSTECTOMY; HUMAN; HYPOXIA; LYMPH NODE DISSECTION; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SURGICAL APPROACH; SURGICAL TECHNIQUE; SURVIVAL RATE;

EID: 79952445528     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2011.5     Document Type: Article

References (10)

1. Ott, O. J. et al. Radiochemotherapy for bladder cancer. Clin. Oncol. (R. Coll. Radiol.) 21, 557-565 (2009).
2. Kaanders, J. H., J. Bussink, J. & van der Kogel, A. J. Clinical studies of hypoxia modification in radiotherapy. Semin. Radiat Oncol. 14, 233-240 (2004). (Pubitemid 38903227)
3. Sealy, R., Cridland, S., Barry, L. & Norris, R. Rradiation with misonidazole and hyperbaric oxygen: final report on a randomized trial in advanced head and neck cancer. Int J. Radiat Oncol. Biol. Phys. 12, 1343-1346 (1986). (Pubitemid 16030613)
4. Hoskin, P J., Rojas, A. M., Bentzen, S. M. & Saunders, M. I. Radiotherapy with concurrent carbogen and nicotinamide in bladder carcinoma. J. Clin. Oncol. 28, 4912-4918 (2010).
5. Milosevic, M. et al. Radiotherapy for bladder cancer. Urology 69 (1 suppl.), 80-92 (2007). (Pubitemid 46186481)
6. Pos, F. & Remeijer, P Adaptive management of bladder cancer radiotherapy. Semin. Radiat Oncol. 20, 116-120 (2010).
7. Chai, X. et al. Behavior of lipiodol markers during image guided radiotherapy of bladder cancer. Int J. Radiat Oncol. Biol. Phys. 77, 309-314 (2010).
8. Pos, F. et al. Lipiodol injection for target volume delineation and image guidance during radiotherapy for bladder cancer. Radiother. Oncol. 93, 364-367 (2009).
9. Rödel, C. & sauer, R. what is the role of radiotherapy in bladder-preserving cancer therapy? Nat Clin. Pract Oncol. 2, 4-5 (2005). (Pubitemid 40823171)
10. Coppin, C. M. et al. improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The national Cancer institute of Canada Clinical Trials Group. J. Clin. Oncol. 14, 2901-2907 (1996). (Pubitemid 26371447)